Lead party: Johnson & Johnson Impact Ventures (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Penda Health Limited (private company) · Sector: Healthcare, Telemedicine Providers, Primary Care Providers · Countries of operation: Kenya
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity) · Round: Growth Capital
Lead investor/buyer: Johnson & Johnson Impact Ventures · Investors/buyers: Johnson & Johnson Impact Ventures
Legal advisers: not identified in the source record.
Source: announced 16 March 2023. Original announcement: jnj.com.


